Evaluation and Management of Elevated Blood Pressure in Children and Adolescents with Attention Deficit Hyperactivity Disorder

被引:3
|
作者
Yamaguchi, Ikuyo [1 ,2 ]
Hanevold, Coral [1 ,2 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Div Nephrol, Dept Pediat, 7703 Floyd Curl Dr,Mail Code 7813, San Antonio, TX 78229 USA
[2] Univ Washington, Seattle Childrens Hosp, Div Nephrol, Dept Pediat,Sch Med, 4800 Sand Point Way NE, Seattle, WA 98105 USA
关键词
ADHD; Pediatric hypertension; Elevated blood pressure; Stimulants; Cardiovascular disease; SERIOUS CARDIOVASCULAR EVENTS; CONGENITAL HEART-DISEASE; DEFICIT/HYPERACTIVITY DISORDER; ADHD MEDICATIONS; CARDIAC SAFETY; UNITED-STATES; HYPERTENSION; POPULATION; STIMULANTS; PREVALENCE;
D O I
10.1007/s11906-019-0968-1
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Purpose of ReviewTo understand the impact of attention deficit hyperactivity disorder (ADHD) and its medications on blood pressure (BP) in children and adolescents and provide recommendations for management of elevated BP in children and adolescents with ADHD.Recent FindingsADHD medications have cardiovascular effects including elevated BP. However, the bulk of the evidence indicates that stimulants and other ADHD medications are safe and do not cause severe cardiovascular diseases. BP should be assessed carefully at the time of ADHD diagnosis, because some behavioral changes similar to ADHD may be associated with hypertension.SummaryADHD medications appear to be safe. However, their long-term impact on the cardiovascular system is not clearly understood and needs further investigation. BP should be monitored regularly during ADHD pharmacotherapy in order to optimize the management of both conditions.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Elevated neutrophil-to-lymphocyte ratio in children and adolescents with attention-deficit/hyperactivity disorder
    Onder, Arif
    Coban, Ozge Gizli
    Adanir, Asli Surer
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2021, 25 (01) : 43 - 48
  • [22] Diagnosis and management of children with attention deficit hyperactivity disorder
    Prahbhjot Malhi
    Pratibha Singhi
    The Indian Journal of Pediatrics, 2001, 68 (6) : 547 - 555
  • [23] The management of attention deficit-hyperactivity disorder in children
    Schellack, Natalie
    Meyer, Hannalie
    SA PHARMACEUTICAL JOURNAL, 2012, 79 (10) : 12 - 20
  • [24] Bacomind® For the Management of Attention Deficit Hyperactivity Disorder in Children
    Dave, Usha Pinakin
    Dingankar, Sunila Rajeev
    Saxena, Vinod Swaroop
    Allan, Joseph Joshua
    Bethapudi, Bharathi
    Agarwal, Amit
    INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 : S121 - S121
  • [25] Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
    Storebo, Ole Jakob
    Storm, Maja Rosenberg Overby
    Ribeiro, Johanne Pereira
    Skoog, Maria
    Groth, Camilla
    Callesen, Henriette E.
    Schaug, Julie Perrine
    Rasmussen, Pernille Darling
    Huus, Christel-Mie L.
    Zwi, Morris
    Kirubakaran, Richard
    Simonsen, Erik
    Gluud, Christian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (03):
  • [26] Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
    Storebo, Ole Jakob
    Ramstad, Erica
    Krogh, Helle B.
    Nilausen, Trine Danvad
    Skoog, Maria
    Holmskov, Mathilde
    Rosendal, Susanne
    Groth, Camilla
    Magnusson, Frederik L.
    Moreira-Maia, Carlos R.
    Gillies, Donna
    Rasmussen, Kirsten Buch
    Gauci, Dorothy
    Zwi, Morris
    Kirubakaran, Richard
    Forsbol, Bente
    Simonsen, Erik
    Gluud, Christian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (11):
  • [27] Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder
    Witcher, JW
    Long, A
    Smith, B
    Sauer, JM
    Heilgenstein, J
    Wilens, T
    Spencer, T
    Biederman, J
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (01) : 53 - 63
  • [28] Efficacy of atomoxetine in children and adolescents with attention deficit/hyperactivity disorder
    Yamamuro, K.
    Ueda, J.
    Takada, R.
    Yoshikawa, H.
    Aoki, C.
    Inoue, Y.
    Azechi, T.
    Yamamoto, S.
    Furuyama, T.
    Kishimoto, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S713 - S714
  • [29] Effectiveness of strattera in children and adolescents with attention deficit hyperactivity disorder
    Vakula, I. N.
    Vasyanina, Yu Sh.
    Gorbunova, Z. H.
    Nikiforova, E. Yu.
    Ponomarenko, E. I.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2009, 109 (08) : 42 - 44
  • [30] Efficacy of Attention Deficit Hyperactivity Disorder treatments in children and adolescents
    Jarque Fernandez, Sonia
    ANUARIO DE PSICOLOGIA, 2012, 42 (01): : 19 - U134